Burning Rock Biotech vs Standard Biotools
Burning Rock Biotech and Standard Biotools are similar in size: $75.1m and $85.3m of revenue in their latest fiscal years. Burning Rock Biotech grew faster (4.7% against -6.2%). Burning Rock Biotech kept more of each dollar of sales as profit: a net margin of -10.3% against -87.8%.
| Latest fiscal year | Burning Rock BiotechBNR, 2025 | Standard BiotoolsLAB, 2025 |
|---|---|---|
| Revenue | $75.1m | $85.3m |
| Revenue growth | 4.7% | -6.2% |
| Net income | −$7.7m | −$74.9m |
| Operating margin | — | -129.2% |
| Net margin | -10.3% | -87.8% |
| Return on equity | -9.9% | -16.7% |
| Free cash flow | −$4.7m | −$82.6m |
| Cash | $68.4m | $121m |
| Total debt | $243,097 | $299,000 |
| Debt to equity | — | 0.1% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $0 |
| Employees | — | 389 |
| Market value | $115m | $241m |
| Price vs our value range | — | — |
| Moat score | — | 20 (Weak) |
| Insider trades, 12 months | 8 buys, 0 sales | 15 buys, 0 sales |